- Report
- March 2024
- 199 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- March 2024
- 186 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- October 2023
- 171 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- December 2023
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- February 2022
- 80 Pages
Global
From €2658EUR$2,750USD£2,285GBP
€5317EUR$5,500USD£4,570GBP
- Report
- April 2023
- 100 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €918EUR$950USD£789GBP
- Report
- July 2019
- 340 Pages
Global
From €4205EUR$4,350USD£3,614GBP
- Report
- March 2022
Global
From €4689EUR$4,850USD£4,030GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €918EUR$950USD£789GBP
- Book
- February 2012
- 648 Pages
The HDL Test market is a subset of the Cholesterol Testing market. It is a diagnostic test used to measure the amount of high-density lipoprotein (HDL) cholesterol in the blood. HDL cholesterol is known as the “good” cholesterol because it helps remove other forms of cholesterol from the body. The HDL Test market is composed of a variety of products and services, including test kits, reagents, and laboratory services.
The HDL Test market is driven by the increasing prevalence of cardiovascular diseases, the growing demand for preventive healthcare, and the rising awareness of cholesterol testing. Additionally, the development of innovative products and services, such as point-of-care testing, is expected to further drive the market.
Some companies in the HDL Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Thermo Fisher Scientific, and Quest Diagnostics. Show Less Read more